Alison Searle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

07 Apr 2021
Part 2 of a two-part story. Click here for Part 1.
The COVID-19 pandemic has touched every aspect of health, from neurologic disease broadly (see Part 1 of this story) to clinical research. At the 15th International Conference on Alzheimer s and Parkinson s Diseases, held virtually March 9–14, clinical investigators talked about how they tried to prevail despite interruptions and preserve their trials. Looking to the future, how they will handle people who had COVID-19, or develop it during a trial, remains unclear.
Home nursing allowed dosing to continue in Roche s gantenerumab trials.
Other trials used telemedicine to continue recruitment and interventions.
How will researchers include people who had COVID in clinical trials? ....

New York , United States , Winston Salem , North Carolina , Region Flamande , Columbia University , Mark Espeland , Tomislav Babic , Roy Alcalay , Ronald Petersen , Roger Nitsch , Chelsea Weidman Burke , Alison Searle , Wake Forest School Of Medicine , International Conference On Alzheimer , International Conference , Mayo Clinic , Worldwide Clinical Trials , Wake Forest School , Chelsea Weidman , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , வின்ஸ்டன் ஸேலம் , வடக்கு கரோலினா , கொலம்பியா பல்கலைக்கழகம் , ரொனால்ட் பீட்டர்சன் ,